James C. Kauer
20Patents
14h-index
18Co-inventors
78Inventor score
Filing activity: Sep 19, 1975 → May 25, 1999
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5093317A | Treating disorders by application of insulin-like growth factor | Chemistry; Metallurgy | 125 | Expired |
| US4762881A | Photoreactive benzoylphenylalanines and related peptides | Emerging Cross-Sectional Technologies | 86 | Expired |
| US5614649A | Multicatalytic protease inhibitors | Chemistry; Metallurgy | 38 | Expired |
| US5461146A | Selected protein kinase inhibitors for the treatment of neurological disorders | Human Necessities | 37 | Expired |
| US5776897A | Treating disorders by application of insulin-like growth factors and analogs | Chemistry; Metallurgy | 35 | Expired |
| US5550262A | Multicatalytic protease inhibitors | Chemistry; Metallurgy | 33 | Expired |
| US5990083A | Multicatalytic protease inhibitors | Chemistry; Metallurgy | 32 | Expired |
| US5652214A | Treating disorders by application of insulin-like growth factors and analogs | Chemistry; Metallurgy | 32 | Expired |
| US5703045A | Treating disorders by application of insulin-like growth factors and analogs | Chemistry; Metallurgy | 32 | Expired |
| US5134121A | Nerve growth factor peptides | Emerging Cross-Sectional Technologies | 28 | Expired |
| US5621101A | Protein kinase inhibitors for treatment of neurological disorders | Human Necessities | 27 | Expired |
| US5621100A | K-252a derivatives for treatment of neurological disorders | Human Necessities | 23 | Expired |
| US3997565A | Acylcrownether oximes and oxime ethers | Emerging Cross-Sectional Technologies | 17 | Expired |
| US4511390A | Aralkylcarbamoyl peptide alcohols | Chemistry; Metallurgy | 14 | Expired |
| US5830870A | Multicatalytic protease inhibitors | Chemistry; Metallurgy | 12 | Expired |
| US4104275A | Heteroaryl crown ethers | Chemistry; Metallurgy | 10 | Expired |
| US5756494A | Protein kinase inhibitors for treatment of neurological disorders | Human Necessities | 10 | Expired |
| US4024158A | Aroylcrownethers | Chemistry; Metallurgy | 6 | Expired |
| US6693076B1 | Treating disorders by application of insulin-like growth factors and analogs | Chemistry; Metallurgy | 4 | Expired |
| US5741808A | Protein kinase inhibitors for treatmen of neurological disorders | Human Necessities | 4 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.